HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter U Heuschmann Selected Research
Peter U Heuschmann Research Topics
Disease
53
Stroke (Strokes)
05/2024 - 05/2003
29
Ischemic Stroke
05/2024 - 05/2003
14
Atrial Fibrillation
10/2023 - 01/2008
6
Heart Failure
07/2022 - 03/2011
5
Inflammation (Inflammations)
10/2023 - 01/2015
5
Coronary Disease (Coronary Heart Disease)
01/2021 - 10/2007
5
Hypertension (High Blood Pressure)
01/2021 - 04/2012
4
Breast Neoplasms (Breast Cancer)
10/2023 - 10/2018
4
Neoplasms (Cancer)
01/2023 - 10/2018
4
Myocardial Infarction
06/2018 - 08/2013
4
Deglutition Disorders (Dysphagia)
12/2017 - 01/2015
3
Disease Progression
06/2019 - 01/2015
2
Infections
03/2024 - 12/2017
2
COVID-19
03/2024 - 01/2024
2
Vascular Diseases (Vascular Disease)
12/2023 - 07/2022
2
Ischemia
11/2023 - 06/2018
2
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2017
2
Diabetes Mellitus
01/2021 - 08/2013
2
Atherosclerosis
01/2021 - 05/2011
2
Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2019
2
Acute Kidney Injury (Acute Renal Failure)
01/2018 - 09/2014
2
Pneumonia (Pneumonitis)
12/2017 - 01/2015
2
Cardiac Arrhythmias (Arrythmia)
11/2017 - 08/2012
2
Cerebral Hemorrhage
10/2017 - 02/2016
2
Hemorrhage
02/2016 - 08/2013
2
Hyperglycemia
05/2015 - 08/2013
1
Fatigue
03/2024
1
Chronic Disease (Chronic Diseases)
03/2024
1
Autoimmune Diseases of the Nervous System
12/2023
1
Reperfusion Injury
11/2023
1
Hypoxia (Hypoxemia)
11/2023
1
Infarction (Infarctions)
11/2023
1
Embolism (Embolus)
10/2023
1
Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
06/2023
1
Post-Acute COVID-19 Syndrome
06/2023
Drug/Important Bio-Agent (IBA)
13
Anticoagulants
IBA
01/2021 - 02/2012
10
Vitamin K
FDA Link
01/2022 - 10/2012
9
Biomarkers (Surrogate Marker)
IBA
05/2024 - 08/2013
7
N(4)-oleylcytosine arabinoside
IBA
01/2022 - 02/2016
5
Troponin T (Troponin T1)
IBA
12/2022 - 08/2011
4
Antihypertensive Agents (Antihypertensives)
IBA
01/2019 - 01/2011
4
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2015 - 05/2003
3
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
12/2023 - 11/2019
3
Antibodies
IBA
12/2023 - 11/2019
3
Immunoglobulin M (IgM)
IBA
06/2023 - 11/2019
3
Troponin
IBA
12/2022 - 08/2011
3
danaparoid (Orgaran)
FDA Link
01/2020 - 05/2011
3
Indicators and Reagents (Reagents)
IBA
01/2017 - 10/2006
2
Glial Fibrillary Acidic Protein
IBA
02/2024 - 11/2023
2
C-Reactive Protein
IBA
10/2023 - 12/2022
2
Immunoglobulin A (IgA)
IBA
10/2022 - 11/2019
2
Immunoglobulin G (IgG)
IBA
10/2022 - 11/2019
2
salicylhydroxamic acid (SHAM)
IBA
01/2020 - 01/2019
2
Cholesterol
IBA
01/2018 - 04/2012
2
Albumins
IBA
01/2017 - 01/2015
2
Creatinine
IBA
01/2017 - 01/2015
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
10/2015 - 01/2015
2
insulin receptor-related receptor (IRR)
IBA
01/2015 - 08/2008
2
Lipids
IBA
04/2012 - 03/2011
2
Tobacco Smoke Pollution (Passive Smoking)
IBA
12/2007 - 10/2007
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
05/2024
1
pro-brain natriuretic peptide (1-76)
IBA
05/2024
1
Procalcitonin
IBA
05/2024
1
Hydrocortisone (Cortisol)
FDA Link
Generic
05/2024
1
Atrial Natriuretic Factor (ANF)
IBA
05/2024
1
CI 22
IBA
03/2024
1
Prednisolone (Predate)
FDA Link
Generic
01/2024
1
Vitamin B Complex (B Vitamins)
IBA
01/2024
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
12/2023
1
Autoantibodies
IBA
12/2023
1
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
12/2023
1
Vascular Endothelial Growth Factor B
IBA
12/2023
1
Complement System Proteins (Complement)
IBA
12/2023
1
Synucleins
IBA
11/2023
1
Endoglin
IBA
11/2023
1
Fibronectins (Fibronectin)
IBA
06/2023
1
DNA (Deoxyribonucleic Acid)
IBA
01/2023
1
Trinitrotoluene (TNT)
IBA
12/2022
1
Membrane Proteins (Integral Membrane Proteins)
IBA
07/2022
1
HMGB1 Protein (HMG1)
IBA
07/2022
1
Adenosine Diphosphate (ADP)
IBA
07/2022
1
apixaban
IBA
01/2022
1
Sugars
IBA
01/2022
1
Triglycerides (Triacylglycerol)
IBA
01/2022
1
Factor Xa Inhibitors
IBA
01/2022
1
Glucose (Dextrose)
FDA Link
Generic
01/2022
1
Natriuretic Peptides
IBA
01/2021
1
2,6-dinitrotoluene (DNT)
IBA
01/2021
1
Factor XII (Hageman Factor)
IBA
12/2020
Therapy/Procedure
13
Therapeutics
03/2024 - 05/2003
10
Secondary Prevention
01/2021 - 01/2008
5
Catheter Ablation
10/2023 - 07/2010
5
Length of Stay
10/2017 - 01/2008
5
Thrombolytic Therapy
01/2017 - 05/2003
4
Thrombectomy
02/2024 - 04/2016
3
Aftercare (After-Treatment)
10/2023 - 10/2018
2
Deep Brain Stimulation
01/2020 - 01/2019
2
Nursing Care
09/2011 - 01/2009
1
Adjuvant Chemotherapy
01/2023
1
Precision Medicine
01/2023